DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Azacitidineis the generic ingredient in three branded drugs marketed by Accord Hlthcare, Actavis Llc, Cipla, Dr Reddys, Eurohlth Intl Sarl, Lupin Ltd, Meitheal, Mylan Institutional, Natco Pharma Ltd, Shilpa Medicare, Celgene, and Celgene Corp, and is included in twelve NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.
Azacitidine has sixty-nine patent family members in thirty-four countries.
There are fifteen drug master file entries for azacitidine. Thirteen suppliers are listed for this compound.
Summary for azacitidine
|Drug Master File Entries:||15|
|Suppliers / Packagers:||13|
|Bulk Api Vendors:||109|
|Formulation / Manufacturing:||see details|
|Drug Prices:||Drug price trends for azacitidine|
|What excipients (inactive ingredients) are in azacitidine?||azacitidine excipients list|
|DailyMed Link:||azacitidine at DailyMed|
Recent Clinical Trials for azacitidine
Identify potential brand extensions & 505(b)(2) entrants
|Aprea Therapeutics||Phase 1|
|Treadwell Therapeutics, Inc||Phase 1/Phase 2|
|The First Affiliated Hospital of Soochow University||Phase 2|
Pharmacology for azacitidine
|Drug Class||Nucleoside Metabolic Inhibitor |
|Mechanism of Action||Nucleic Acid Synthesis Inhibitors |
Medical Subject Heading (MeSH) Categories for azacitidine
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||TE||Type||RLD||RS||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Exclusivity Expiration|
|Celgene Corp||ONUREG||azacitidine||TABLET;ORAL||214120-001||Sep 1, 2020||RX||Yes||No||Start Trial||Start Trial||Start Trial|
|Lupin Ltd||AZACITIDINE||azacitidine||POWDER;INTRAVENOUS, SUBCUTANEOUS||210748-001||Feb 27, 2019||DISCN||No||No||Start Trial||Start Trial||Start Trial|
|Actavis Llc||AZACITIDINE||azacitidine||POWDER;INTRAVENOUS, SUBCUTANEOUS||208216-001||Apr 29, 2016||AP||RX||No||No||Start Trial||Start Trial||Start Trial|
|>Applicant||>Tradename||>Generic Name||>Dosage||>NDA||>Approval Date||>TE||>Type||>RLD||>RS||>Patent No.||>Patent Expiration||>Product||>Substance||>Delist Req.||>Exclusivity Expiration|
Make Better Decisions: Try a trial or see plans & pricing
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.